Pharmacokinetics and biodistribution of a nucleotide-based thrombin inhibitor in rats

Pharmaceutical Research

Volumn 15, Issue 6, 1998, Pages 904-910

  Reyderman, Larisa ^a   Stavchansky, Salomon ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Biodistribution; GS522; Oligodeoxynucleotide; Pharmacokinetics; Rat; Tritiated

Indexed keywords

GS 552; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTITHROMBINS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; ELECTROPHORESIS, CAPILLARY; INJECTIONS, INTRAVENOUS; MALE; OLIGONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; TISSUE DISTRIBUTION;

EID: 0031782408     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011980716659     Document Type: Article

References (19)

1. L. C. Griffin, G. F. Tidmarsh, L. C. Bock, J. J. Toole, and L. L. K. Leung. In vivo Anticoagulant Properties of a Novel Nucleotide-Based Thrombin Inhibitor and Demonstration of Regional Anticoagulation in Extracorporeal Circuits. Blood 81:3271 (1993).
2. W.-X. Li, A. V. Kaplan, G. W. Grant, J. J. Toole, and L. K. Leug. A Novel Nucleotide-Based Thrombin Inhibitor Inhibits Clot-Bound Thrombin and Reduces Arterial Platelet Thrombus Formation. Blood 83:677 (1994).
3. A. DeAnda, S. E. Coutre, M. R. Moon, C. N. Vial, L. C. Griffin, V. S. Law, M. Komeda, L. L. K. Leung, and D. C. Miler. Pilot Study of the Efficacy of a Thrombin Inhibitor for Use During Cardiopulmonary Bypass. Ann. Thorac. Surg. 58:344 (1994).
4. W. A. Lee, J. A. Fishback, J-P. Shaw, L. C. Bock, L. C. Griffin, and K. C. Cundy. A Novel Oligonucleotide Inhibitor of Thrombin. II Pharmacokinetics in the Cynomolgus Monkey. Pharm. Res. 12:1943 (1995).
5. M. J. Graham, S. M. Freier, R. M. Crooke, D. J. Ecker, R. N. Maslova, and E. A. Lesnik. Tritium Labeling of Antisense Oligonucleotides by Exchange with Tritiated Water. Nucl. Acids Res. 21:3737 (1993).
6. L. Reyderman and S. Stavchansky. Quantitative Determination of Short Single-stranded Oligonucleotides From Blood Plasma Using Capillary Electrophoresis With Laser Induced Fluorescence. Anal.Chem., in print (1997).
7. R. Zhang, R. P. Iyer, D. Yu, W. Tan, X. Zhang, Z. Lu, H. Zhqo, and S. Agrawal. Pharmacokinetics and Tissue Disposition of a Chimeric Oligodeoxynucleoside Phosphorothioate in Rats After Intravenous Administration. J. Pharm. Exp. Ther. 278:971 (1996).
8. P. S. Eder, R. J. DeVine, J. M. Dagle, and J. A. Walder. Substrate Specificity and Kinetics of Degradation of Antisense Oligonucleotides by a 3'Exonuclease in Plasma. Antisense Res. Develop. 1:141 (1991).
9. J.-P. Shaw, J. A. Fishback, K. C. Cundy, and W. A. Lee. A Novel Oligonucleotide Inhibitor of Thrombin. I. In Vitro Metabolic Stability in Plasma and Serum. Pharm. Res. 12:1937 (1995).
10. P. C. de Smidt, T. L. Doan, S. de Falco, and T. J. C. van Berkel. Association of Antsense Oligonucleotides with Lipoproteins Prolongs the Plasma Half-life and Modifies the Tissue Distribution. Nucl. Acids. Res. 19:4695 (1991).
11. G. Goodarzi, M. Watabe, and K. Watabe. Organ Distribution and Stability of Phosphorothioated Oligodeoxyribonucleotides in Mice. Biopharm. Drug Disp. 13:221 (1992).
12. S. Agrawal, J. Temsamani, and J. Y. Tang. Pharmacokinetics, Biodistribution, and Stability of Oligodeoxynucleotide Phosphorothioates in Mice. Proc. Natl. Acad. Sci. USA 88:7595 (1991).
13. 14C-Labeled Phosphorothioate Oligonucleotide, ISIS 2105, after Intravenous Administration to Rats. J. Pharmacol. Exp. Ther. 267:1181 (1993).
14. 3H-Labelled Oligonucleotides.I.Comparison of a Phosphodiester and a Phosphorothioate. Mol. Pharmocol. 45:932 (1994).
15. 3H-Labelled Oligonucleotides. II. 3′,5′-Blocked Oligonucleotides. Mol. Pharmacol. 47:636 (1995).
16. H. J. Gaus, S. R. Owens, M. Winniman, S. Cooper, and L. Cummins. On-Line Electrospray Mass Spectrometry of Phosphorothioate Oligonucleotide Metabolites. Anal. Chem. 69:313 (1996).
17. 14C-Labeled Phosphorothioate Oligonucleotide, ISIS 2105, after Intradermal Administration to Rats. J. Pharmacol. Exp. Ther. 267:1181 (1993).
18. J. Rappaport, B. Hanss, J. B. Kopp, T. D. Copeland, L. A. Bruggeman, T. M. Coffman, and P. E. Klotman. Transport of Phosphorothioate Oligonucleotides in Kidney: Implications for Molecular Therapy. Kid. Int. 47:1462 (1995).
19. R. Oberbauer, G. F. Schreiner, and T. W. Meyer. Renal Uptake of an 18-mer Phosphorothioate Oligonucleotide. Kid. Int. 48:1226 (1995).